Opioid use in post-acute hip fracture care: prescribing patterns, effectiveness, and safety
阿片类药物在急性髋部骨折后护理中的使用:处方模式、有效性和安全性
基本信息
- 批准号:9980239
- 负责人:
- 金额:$ 20.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcetaminophenActivities of Daily LivingAcuteAddressAdmission activityAdultAgeAlzheimer&aposs disease related dementiaAnalgesicsBenefits and RisksBody Weight decreasedCaringCertificationCharacteristicsClinicalClinical TrialsClinical assessmentsCognitiveCohort StudiesCommunitiesDataData LinkagesData SetDatabasesDeliriumDrug usageEffectivenessElderlyFractureFutureGoalsHealthHealth care facilityHip FracturesHip region structureHome environmentHospitalizationIndividualInpatientsInvestigationKnowledgeLettersLinkLong-Term CareMeasuresMedicareMedicare Part AMedicare claimMedication ManagementMethodsMorbidity - disease rateNational Institute on AgingNon-Steroidal Anti-Inflammatory AgentsNursing HomesObservational StudyOccupational TherapyOpioidOutcomePainPain managementPatientsPatternPersonsPharmaceutical PreparationsPharmacy facilityPhysical FunctionPhysical therapyPopulationPublic HealthPublishingRecordsRegimenRehabilitation therapyReportingResearchRiskSafetySamplingSkilled Nursing FacilitiesStandardizationSurveysTimeWorkacute careadverse event riskadverse outcomebasebeneficiarycohortcomparativecomparative effectivenesscostdata resourceevidence baseevidence based guidelinesexperimental studyfallsfunctional declinefunctional statushigh riskhospital readmissionimprovedlarge datasetsmedication administrationmortalitymultiple chronic conditionsnon-opioid analgesicnovelolder patientopioid epidemicopioid useopioid usersafety outcomesstudy population
项目摘要
Project Summary
Pain management in older adults is more important during the post-acute care period than at any other time
after hip fracture hospitalization. Pain control can positively impact function and help avert adverse outcomes
like delirium, especially among persons with Alzheimer’s disease and related dementias (ADRD). Annually,
over 300,000 older U.S. adults are discharged to receive rehabilitation in post-acute skilled nursing facilities
(SNFs) after hip fracture, making SNFs a critical place to study analgesic prescribing practices and their impact
following fracture. Pain is often inadequately treated following hip fracture, and there are no evidence-based
guidelines to guide post-hospitalization pain management. Large clinical trials have not been conducted in
post-acute SNFs and until now, observational studies using drug claims data were impossible because drug
dispensing data is not captured by Medicare Part D claims for SNF residents. To effectively and safely treat
pain in older adults with hip fracture, we must understand the drivers and downstream effects of prescribing
different analgesic regimens. This proposal has two specific aims: (1) To describe the individual- (e.g., ADRD)
and facility-level (e.g., staffing) predictors of using different analgesic drug regimens, including those containing
opioids, in post-acute SNF care after hip fracture; and (2) To evaluate the comparative effectiveness (i.e., pain,
functioning) and safety (i.e., rehospitalization) of different analgesic regimens. The rigorous cohort study we
propose will combine novel linked administrative and clinical datasets to identify the medication dispensing
data that are “missing” from Medicare Part D for >60% of all U.S. SNFs, including over-the-counter and pro re
nata (PRN) use. The study population will comprise community-dwelling older adults who were hospitalized for
hip fracture between 2013 and 2016, and then admitted to a nursing home for a SNF stay. Subjects will be
followed for outcomes after SNF admission, comparing those who were initiated on different analgesic
medication regimens in post-acute care. Data for this study will come from (1) a large long-term care
pharmacy, which captures drug use during periods of SNF care where claims data from Part D are unavailable;
(2) the Minimum Data Set version 3.0, a comprehensive database of standardized clinical assessment data;
(3) the Certification and Survey Providence Enhanced Reporting database containing comprehensive facility-
level information collected on facilities; (4) Medicare Part A inpatient claims data; (5) Medicare Part D drug
claims; and (6) medication administration record data for 125 SNFs. Propensity score approaches and other
causal inference methods will be employed. Knowledge gained from this study could provide the first empirical
guidance for the management of post-hip fracture pain in older adults, which could ultimately result in improved
treatment decisions and subsequent patient health outcomes, thereby addressing Strategic Goal C of the
National Institute on Aging. Additionally, the unique database established in this project could be used to
conduct many important future medication-related studies to improve health of older adults in post-acute care.
项目概要
老年人的疼痛管理在急性后期护理期间比任何其他时间都更为重要
髋部骨折住院后。疼痛控制可以积极影响功能并有助于避免不良后果
例如谵妄,尤其是患有阿尔茨海默病和相关痴呆症 (ADRD) 的人。每年,
超过 300,000 名美国老年人出院,在急性后专业护理机构接受康复治疗
(SNF) 髋部骨折后,使 SNF 成为研究镇痛处方实践及其影响的关键场所
骨折后。髋部骨折后的疼痛往往没有得到充分治疗,并且没有基于证据的证据
指导住院后疼痛管理的指南。尚未进行大型临床试验
急性后 SNF 以及迄今为止,使用药物声称数据进行观察性研究是不可能的,因为药物
SNF 居民的 Medicare D 部分索赔未捕获配药数据。为了有效、安全地治疗
对于患有髋部骨折的老年人的疼痛,我们必须了解处方的驱动因素和下游影响
不同的镇痛方案。该提案有两个具体目标: (1) 描述个体(例如 ADRD)
以及使用不同镇痛药物治疗方案的设施层面(例如人员配置)预测因素,包括那些包含
阿片类药物,用于髋部骨折后急性 SNF 护理; (2) 评估比较效果(即疼痛、
不同镇痛方案的功能)和安全性(即再住院)。我们进行了严格的队列研究
提议将结合新颖的关联管理和临床数据集来识别药物配发
超过 60% 的美国 SNF 的 Medicare D 部分“缺失”数据,包括非处方药和专业药
nata (PRN) 使用。研究人群将包括因住院治疗而住院的社区老年人
2013 年至 2016 年间发生髋部骨折,然后入住疗养院进行 SNF 治疗。科目将是
对 SNF 入院后的结果进行随访,比较那些开始使用不同镇痛剂的患者
急性后护理中的药物治疗方案。本研究的数据将来自(1)大型长期护理中心
药房,记录 SNF 护理期间的药物使用情况,而 D 部分的索赔数据不可用;
(2)最小数据集3.0版,标准化临床评估数据的综合数据库;
(3) 认证和调查普罗维登斯增强报告数据库包含综合设施-
收集的设施水平信息; (4) Medicare A 部分住院索赔数据; (5) Medicare D 部分药物
索赔; (6) 125个SNF的用药记录数据。倾向评分方法和其他
将采用因果推理方法。从这项研究中获得的知识可以提供第一个实证
老年人髋部骨折后疼痛管理指南,最终可能导致改善
治疗决策和随后的患者健康结果,从而实现战略目标 C
国家老龄化研究所。此外,该项目中建立的独特数据库可用于
开展许多重要的未来药物相关研究,以改善老年人急性期后护理的健康。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparing Treatment Response Between Older and Younger Patients with Chronic Hepatitis C Virus Infection on Direct-acting Antiviral Agents.
比较老年和年轻慢性丙型肝炎病毒感染患者对直接作用抗病毒药物的治疗反应。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Francis,AlyssaK;Beaudoin,FrancescaL;Naidjate,SafiyaS;Berard-Collins,Christine;Zullo,AndrewR
- 通讯作者:Zullo,AndrewR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Francesca Beaudoin其他文献
Francesca Beaudoin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Francesca Beaudoin', 18)}}的其他基金
Injury Control Research to Practice and Policy Core
伤害控制研究实践和政策核心
- 批准号:
10331945 - 财政年份:2022
- 资助金额:
$ 20.27万 - 项目类别:
Identifying optimal buprenorphine dosing for OUD treatment and prevention of overdose
确定 OUD 治疗的最佳丁丙诺啡剂量和预防过量
- 批准号:
10524852 - 财政年份:2022
- 资助金额:
$ 20.27万 - 项目类别:
Injury Control Research to Practice and Policy Core
伤害控制研究实践和政策核心
- 批准号:
10598065 - 财政年份:2022
- 资助金额:
$ 20.27万 - 项目类别:
Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
通过数字健康在 COVID-19 期间增加 OUD 恢复的同行支持:一项全国随机对照试验
- 批准号:
10459602 - 财政年份:2021
- 资助金额:
$ 20.27万 - 项目类别:
Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
通过数字健康在 COVID-19 期间增加 OUD 恢复的同行支持:一项全国随机对照试验
- 批准号:
10672255 - 财政年份:2021
- 资助金额:
$ 20.27万 - 项目类别:
Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
通过数字健康在 COVID-19 期间增加 OUD 恢复的同行支持:一项全国随机对照试验
- 批准号:
10308885 - 财政年份:2021
- 资助金额:
$ 20.27万 - 项目类别:
相似海外基金
Determining 4-Dimensional Foot Loading Profiles of Healthy Adults across Activities of Daily Living
确定健康成年人日常生活活动的 4 维足部负荷曲线
- 批准号:
2473795 - 财政年份:2024
- 资助金额:
$ 20.27万 - 项目类别:
Studentship
Developing a trunk function assessment for hemiplegics. -For improving activities of daily living-
开发偏瘫患者的躯干功能评估。
- 批准号:
23K10540 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relation with the activities of daily living and the subjective values among people with social withdrawal
社交退缩者日常生活活动与主观价值观的关系
- 批准号:
23K16596 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CRII: RI: Understanding Activities of Daily Living in Indoor Scenarios
CRII:RI:了解室内场景中的日常生活活动
- 批准号:
2245652 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Standard Grant
Sources of vulnerability among those using homecare despite having no limitations in Activities of Daily Living. An intersectionality analysis
尽管日常生活活动没有限制,但使用家庭护理的人的脆弱性来源。
- 批准号:
499112 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Operating Grants
Association between Nursing Care and Prognosis and Activities of Daily Living in Acute Stroke patients by using Big Data.
利用大数据研究急性脑卒中患者的护理与预后和日常生活活动的关系。
- 批准号:
23K16412 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of a model of nurses-occupational therapists collaborative practice on activities of daily living in elderly patients
护士-职业治疗师合作实践模式对老年患者日常生活活动的影响
- 批准号:
22K17540 - 财政年份:2022
- 资助金额:
$ 20.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
- 批准号:
10429480 - 财政年份:2022
- 资助金额:
$ 20.27万 - 项目类别:
Assessing a Novel Virtual Environment that Primes Individuals Living with AD/ADRD to Accomplish Activities of Daily Living.
评估一种新颖的虚拟环境,该环境可以帮助 AD/ADRD 患者完成日常生活活动。
- 批准号:
10668160 - 财政年份:2022
- 资助金额:
$ 20.27万 - 项目类别:
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
- 批准号:
10621820 - 财政年份:2022
- 资助金额:
$ 20.27万 - 项目类别: